Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Callies

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Zentralblatt Fur Gynakologie|January 1, 1984
[Treatment results in malignant tumors of the vulva, a retrospective analysis of 119 cases]R Callies, U Kock, G X Zeller, et al.
Archives of Gynecology and Obstetrics|January 1, 1996
Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parametersP A Regidor, R Callies, M Regidor, et al.
Gynakologisch-Geburtshilfliche Rundschau|July 11, 1998
[Detection of endometriosis during cesarean section for HELLP syndrome in the 32nd week of pregnancy]P A Regidor, E M Kind, R Callies, et al.
BMC Cancer|August 11, 2016
Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancerJ D Kuhlmann, A Bankfalvi, K W Schmid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II studyK Höffken, W Jonat, K Possinger, et al.
Medizinische Klinik (Munich, Germany : 1983)|October 3, 1986
[Low-dose aminoglutethimide therapy without cortisol substitution in postmenopause metastasizing breast cancer]K Höffken, A A Miller, B Miller, et al.
Virchows Archiv : an International Journal of Pathology|October 7, 2005
Relationship and prognostic significance of phospho-(serine 166)-murine double minute 2 and Akt activation in node-negative breast cancer with regard to p53 expressionK J Schmitz, F Grabellus, R Callies, et al.
Journal of Clinical Pathology|February 25, 2006
Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathwaysK J Schmitz, R Callies, J Wohlschlaeger, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Zentralblatt Fur Gynakologie|January 1, 1984
[Treatment results in malignant tumors of the vulva, a retrospective analysis of 119 cases]R Callies, U Kock, G X Zeller, et al.
Archives of Gynecology and Obstetrics|January 1, 1996
Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parametersP A Regidor, R Callies, M Regidor, et al.
Gynakologisch-Geburtshilfliche Rundschau|July 11, 1998
[Detection of endometriosis during cesarean section for HELLP syndrome in the 32nd week of pregnancy]P A Regidor, E M Kind, R Callies, et al.
BMC Cancer|August 11, 2016
Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancerJ D Kuhlmann, A Bankfalvi, K W Schmid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II studyK Höffken, W Jonat, K Possinger, et al.
Medizinische Klinik (Munich, Germany : 1983)|October 3, 1986
[Low-dose aminoglutethimide therapy without cortisol substitution in postmenopause metastasizing breast cancer]K Höffken, A A Miller, B Miller, et al.
Virchows Archiv : an International Journal of Pathology|October 7, 2005
Relationship and prognostic significance of phospho-(serine 166)-murine double minute 2 and Akt activation in node-negative breast cancer with regard to p53 expressionK J Schmitz, F Grabellus, R Callies, et al.
Journal of Clinical Pathology|February 25, 2006
Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathwaysK J Schmitz, R Callies, J Wohlschlaeger, et al.
Pageof 6